Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled to have a catheter ablation procedure (a heart procedure using thin, flexible tubes) for a type of irregular heartbeat called persistent atrial fibrillation, where the irregular heartbeat has been present for less than 24 months and no previous ablation procedure has been done on the left side of the heart.
- People who are willing and able to give their informed consent to participate.
Who may not be able to join:
- People who are unwilling to sign the consent form.
- People under 18 years of age.
- People who have medical reasons that make a catheter ablation procedure unsafe or unsuitable for them (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 020 3765 8682
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sequential rate dependent conduction velocity (RDCV) assessment; Ablation of RDCV slowing results in an positive ablation response.; Autonomic modulation impacts on conduction velocity measurements.; Autonomic modulation impacts on conduction velocity measurements.; Substrate guided ablation in patients with LVZs impacts freedom from AF/AT during follow-up.; Ablation of GP sites results in an positive ablation response.; Substrate guided ablation in patients without LVZs impacts freedom from AF/AT during follow-up.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.